Creating a comprehensive research strategy for cutaneous neurofibromas.

Area of Science:

• Oncology
• Genetics
• Dermatology

Background:

• Cutaneous neurofibromas (cNF) significantly impact quality of life for up to 99% of Neurofibromatosis type 1 (NF1) patients.
• Currently, no established medical treatments exist for cNF, with surgery being the primary option.

Purpose of the Study:

• To address critical knowledge gaps and facilitate the development of effective therapeutics for cNF.
• To convene a multidisciplinary think tank to identify core research questions for cNF treatment development.

Main Methods:

• A think tank comprising experts from academia, industry, and government was assembled.
• Experts from diverse disciplines collaborated to review existing data and identify unknowns relevant to cNF therapeutics.
• Monthly meetings and a research summit were utilized to prioritize questions and organize supporting data.

Main Results:

• Four key themes emerged: cNF definition, tumor biology, therapy development factors, and clinical trial design.
• Specific considerations and questions were identified within each thematic area.
• The identified questions formed the basis for a funding opportunity focused on cNF research.

Conclusions:

• A structured research strategy is essential for advancing cNF therapeutics.
• The identified research priorities and questions will guide future investigations and funding initiatives.
• This work aims to accelerate the development of much-needed treatments for cNF in NF1 patients.